Not applicableStudy completedNCT04911088What this trial is testingElectromyographic Calibration Guided by Depth of AnesthesiaWho this might be right forNeuromuscular Blockade University Hospital Ulm 66
Not applicableLooking for participantsNCT06386354What this trial is testingResidual Neuromuscular Block in the Post-Anesthetic Unit and Postoperative ComplicationsWho this might be right forPostoperative Neuromuscular BlockPostoperative Complications Dr. Negrin University Hospital 296
Not applicableActive Not RecruitingNCT05029869What this trial is testingMonitoring Minimal Residual Disease in Gastric Cancer by Liquid Biopsy Study DescriptionWho this might be right forGastric CancerctDNA University Medical Center Ho Chi Minh City (UMC) 100
Not applicableLooking for participantsNCT06697483What this trial is testingRisk Stratification and MRD-driven Maintenance for MM After ASCTWho this might be right forMultiple Myeloma Peking University People's Hospital 100
Not applicableUnknownNCT04362462What this trial is testingMolecular Profiling After Neoadjuvant Chemotherapy for Triple-negative Breast CancerWho this might be right forTriple-negative Breast Cancer Texas Tech University Health Sciences Center, El Paso 120
Large-scale testing (Phase 3)Looking for participantsNCT05633654What this trial is testingStudy of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)Who this might be right forTriple Negative Breast Cancer Gilead Sciences 1,514
Not applicableNot Yet RecruitingNCT07413146What this trial is testingNeoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled TrialWho this might be right forMinimal Residual DiseaseImmunoscoreNeoadjuvant Chemotherapy+1 more Sun Yat-sen University 100
Large-scale testing (Phase 3)Study completedNCT01864746What this trial is testingPalbociclib in Addition to Standard Endocrine Treatment in Hormone Receptor Positive Her2 Normal Patients With Residual Disease After Neoadjuvant Chemotherapy and SurgeryWho this might be right forBreast CancerHormonreceptor PositiveHer2-normal+2 more GBG Forschungs GmbH 1,250
Post-approval studies (Phase 4)Study completedNCT03923556What this trial is testingSugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade at the End of Kidney Transplantation SurgeryWho this might be right forKidney Transplant; ComplicationsPostoperative Residual CurarizationPostoperative Residual Weakness University of Colorado, Denver 84
Not applicableStudy completedNCT01963429What this trial is testingComparison Between Radiofrequency Ablation and Hypofractionated Proton Beam Radiation for Recurrent/Residual HCCWho this might be right forRecurrent Small Hepatocellular CarcinomaResidual Small Hepatocellular Carcinoma National Cancer Center, Korea 144
Testing effectiveness (Phase 2)Study completedNCT02567253What this trial is testingIntraoperative Intraperitoneal Chemoperfusion to Treat Peritoneal Minimal Residual Disease in Stage III Ovarian CancerWho this might be right forOvarian CancerPrimary Peritoneal Cancer University Hospital, Ghent 56
Post-approval studies (Phase 4)Study completedNCT06105827What this trial is testingClinical Study of Ningmitai Capsule on Promoting the Passage of Residual Fragments After Ureteroscopic LithotripsyWho this might be right forUreteral Calculi Xintian Pharmaceutical 251
Testing effectiveness (Phase 2)Study completedNCT02789254What this trial is testingFLYSYN in MRD Positive AMLWho this might be right forAcute Myeloid Leukemia Synimmune GmbH 31
Not applicableLooking for participantsNCT06963307What this trial is testingNovel Epigenetic Mapping in Cell-Free DNA for the Detection of Lung CancerWho this might be right forLung Cancer, Non-Small Cell JaxBio Ltd 300
Not applicableActive Not RecruitingNCT02633111What this trial is testingDNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin LymphomasWho this might be right forB-cell Non-Hodgkin LymphomaAggressive Memorial Sloan Kettering Cancer Center 501
Testing effectiveness (Phase 2)Looking for participantsNCT06992336What this trial is testingCirculating Tumor DNA Guided Boost Therapy in Early Triple Negative Breast Patients With Residual Disease After Neoadjuvant TherapyWho this might be right forBreast Cancer Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 411
Testing effectiveness (Phase 2)Active Not RecruitingNCT03756298What this trial is testingEfficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast CancerWho this might be right forTriple Negative Breast Cancer National Cancer Center, Korea 284
Not applicableUnknownNCT05228223What this trial is testingComparison of Sugammadex and Sugammadex-neostigmine Combination in the Antagonism of Moderate Neuromuscular BlockWho this might be right forResidual Neuromuscular BlockNeuromuscular Blockade Monitoring Ankara City Hospital Bilkent 90
Not applicableUnknownNCT05266625What this trial is testingDigital Therapeutic Based Investigation to Improve Glycemic Control in Patients With Type 2 Diabetes and Residual Hyperglycemia on Stable Medical TherapyWho this might be right forDiabetes Mellitus, Type 2 Better Therapeutics 500
Not applicableStudy completedNCT02230410What this trial is testingCryo Balloon for Residual Barrett's EsophagusWho this might be right forBarrett's Esophagus Mayo Clinic 18